Mem Inst Oswaldo Cruz, Rio de Janeiro, VOLUME 121 | 2026
Research Articles

Immune dysregulation, apoptosis impairment, and enhanced seroreactivity to Anisakis simplex in Crohn’s disease: interplay of IL-7/IL-7R signalling and CD132 deficiency

Carmen Cuéllar1,2,+, Carolina Hurtado-Marcos3, Elizabeth Valdivieso3, Lucianna Vaccaro3, Juan González-Fernández1,2, Ana Isabel Jiménez4, Jaume Pérez-Griera5, Salvador Benlloch6,7, Cirilo Amorós6, Rafael Gil-Borrás7, Rosa Sorando-Serra8, María José Cano-Cano8, Juan Carlos Andreu-Ballester2,9

1Complutense University of Madrid, Department of Microbiology and Parasitology, Madrid, Spain
2Complutense University of Madrid, Parasitic Immunobiology and Immunomodulation Research Group, Madrid, Spain
3CEU Universities, Universidad CEU San Pablo, Urbanización Montepríncipe, Boadilla del Monte, Spain
4Arnau de Vilanova Hospital, Biopathology Department, Valencia, Spain
5University Clinical Hospital, Laboratory Department, Valencia, Spain
6Arnau de Vilanova Hospital, Digestive Departament, Valencia, Spain
7CEU Universities, Cardenal Herrera, Valencia, Spain
8Arnau de Vilanova Hospital, Emergency Department, Valencia, Spain
9Foundation for the Promotion of Health and Biomedical Research in the Valencian Region, Benimaclet, Valencia, Spain

DOI: 10.1590/0074-02760250129
490 views 563 downloads
ABSTRACT

BACKGROUND In previous studies, we identified a deficiency of γδ T cells and an increased prevalence of anti-Anisakis simplex antibodies in patients with Crohn’s disease (CD). Additionally, decreased gene expression of the interleukin 2 (IL-2) receptor γ subunit (CD132) was observed in tissues from CD patients.
OBJECTIVE To analyse the gene expression of IL-7 and its receptors in tissues from CD patients and to explore its relationship with anti-A. simplex antibodies.
METHODS 52 patients diagnosed with CD were compared with a control group of 52 healthy individuals. Peripheral blood samples were analysed to assess levels of anti-A. simplex antibodies and IL-7. In addition, intestinal tissue samples from 20 subjects in each group were examined to evaluate IL-7 gene expression, IL-7 protein levels, the IL-2 receptor γ subunit (CD132), the IL-7 receptor α subunit (CD127), and caspase-3 expression.
FINDINGS Anti-A. simplex antibody levels were elevated in patients with CD. Caspase-3 expression was significantly reduced in the tissues of CD patients with anti-A. simplex IgA, and this reduction extended to IgG and IgE in healthy individuals. A negative correlation was observed between caspase-3 levels and serum anti-A. simplex IgA, as well as IL-7 levels in the tissues of CD patients. In healthy subjects, tissue IL-7 levels were lower in those positive for anti-A. simplex IgA, while serum IL-7 levels were higher in individuals positive for anti-A. simplex IgG.
MAIN CONCLUSIONS This study revealed the interplay between IL-7 signalling, γδ T cell deficiency, and immune responses to A. simplex in CD. Our findings underscored a cause-effect relationship between CD132 deficiency, γδ T cell depletion, and defective mucosal immunity, which may drive both CD inflammation and susceptibility to parasitic infections like A. simplex.

REFERENCES
01. Dolinger M, Torres J, Vermeire S. Crohn’s disease. Lancet. 2024; 403(10432): 1177-91.
02. Andreu-Ballester JC, Amigo-Garcia V, Catalan-Serra I, Gil-Borras R, Ballester F, Almela-Quilis A, et al. Deficit of gammadelta T lymphocytes in the peripheral blood of patients with Crohn’s disease. Dig Dis Sci. 2011; 56(9): 2613-22.
03. Gilliland A, Chan JJ, De Wolfe TJ, Yang H, Vallance BA. Pathobionts in inflammatory bowel disease: origins, underlying mechanisms, and implications for clinical care. Gastroenterology. 2024; 166(1): 44-58.
04. del Pozo V, Arrieta I, Tunon T, Cortegano I, Gomez B, Cardaba B, et al. Immunopathogenesis of human gastrointestinal infection by Anisakis simplex. J Allergy Clin Immunol. 1999; 104(3 Pt 1): 637-43.
05. Gutierrez R, Cuellar C. Immunoglobulins anti-Anisakis simplex in patients with gastrointestinal diseases. J Helminthol. 2002; 76(2): 131-6.
06. Baron L, Branca G, Trombetta C, Punzo E, Quarto F, Speciale G, et al. Intestinal anisakidosis: histopathological findings and differential diagnosis. Pathol Res Pract. 2014; 210(11): 746-50.
07. de la Hoz-Martin MP, Gonzalez-Fernandez J, Andreu-Ballester JC, Hoivik ML, Ricanek P, Bruland T, et al. Prevalence of antianisakis simplex antibodies in a cohort of patients with inflammatory bowel disease in Norway. Pathogens. 2025; 14(8).
08. Aibinu IE, Smooker PM, Lopata AL. Anisakis nematodes in fish and shellfish- from infection to allergies. Int J Parasitol Parasites Wildl. 2019; 9: 384-93.
09. Benet-Campos C, Cuellar C, Garcia-Ballesteros C, Zamora V, Gil- Borras R, Catalan-Serra I, et al. Determination of anti-Anisakis simplex antibodies and relationship with alphabeta and gammadelta lymphocyte subpopulations in patients with Crohn’s disease. Dig Dis Sci. 2017; 62(4): 934-43.
10. Andreu-Ballester JC, Hurtado-Marcos C, Garcia-Ballesteros C, Perez-Griera J, Izquierdo F, Ollero D, et al. Decreased gene expression of interleukin 2 receptor subunit gamma (CD132) in tissues of patients with Crohn’s disease. World J Gastroenterol. 2025; 31(12): 97120.
11. Belarif L, Danger R, Kermarrec L, Nerriere-Daguin V, Pengam S, Durand T, et al. IL-7 receptor influences anti-TNF responsiveness and T cell gut homing in inflammatory bowel disease. J Clin Invest. 2019; 129(5): 1910-25.
12. Guillen-Bueno R, Gutierrez-Ramos R, Perteguer-Prieto MJ, Olveira-Martin A, Fernandez-Blanco I, Pozuelo-Garcia A, et al. Anti-anisakis antibodies in the clinical course of Crohn’s disease. Digestion. 1999; 60(3): 268-73.
13. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl. 1989; 170: 2-6; discussion 16-9.
14. Papay P, Ignjatovic A, Karmiris K, Amarante H, Milheller P, Feagan B, et al. Optimising monitoring in the management of Crohn’s disease: a physician’s perspective. J Crohns Colitis. 2013; 7(8): 653-69.
15. Huang L, Appleton JA. Eosinophils in helminth infection: defenders and dupes. Trends Parasitol. 2016; 32(10): 798-807.
16. Yasuda K, Kuroda E. Role of eosinophils in protective immunity against secondary nematode infections. Immunol Med. 2019; 42(4): 148-55.
17. Jacobs SR, Michalek RD, Rathmell JC. IL-7 is essential for homeostatic control of T cell metabolism in vivo. J Immunol. 2010; 184(7): 3461-9.
18. Cool T, Worthington A, Poscablo D, Hussaini A, Forsberg EC. Interleukin 7 receptor is required for myeloid cell homeostasis and reconstitution by hematopoietic stem cells. Exp Hematol. 2020; 90: 39-45 e3.
19. Maki K, Sunaga S, Komagata Y, Kodaira Y, Mabuchi A, Karasuyama H, et al. Interleukin 7 receptor-deficient mice lack gammadelta T cells. Proc Natl Acad Sci USA. 1996; 93(14): 7172-7.
20. Xu W, Golovchenko NB, Martinez-Vargas IU, Fong A, Rout P, Achi S, et al. Dysregulation of gammadelta intraepithelial lymphocytes precedes Crohn’s disease-like ileitis. Sci Immunol. 2025; 10(105): eadk7429.
21. Ishiguro Y, Kanazawa H, Yamagata K, Sakuraba H, Munakata A. Existence of variant gamma delta T cells in Crohn’s disease. Digestion. 2001; 63 (Suppl. 1): 48-51.
22. Wu D, Wang Z, Zhang J, Robinson AG, Lyu B, Chen Z, et al. Apoptotic caspase inhibits innate immune signaling by cleaving NF-kappaBs in both Mammals and Flies. Cell Death Dis. 2022; 13(8): 731.
23. Murakawa M, Jung SK, Iijima K, Yonehara S. Apoptosis-inducing protein, AIP, from parasite-infected fish induces apoptosis in mammalian cells by two different molecular mechanisms. Cell Death Differ. 2001; 8(3): 298-307.
24. Chulanetra M, Chaicumpa W. Revisiting the mechanisms of immune evasion employed by human parasites. Front Cell Infect Microbiol. 2021; 11: 702125.

+ Corresponding author: cuellarh@ucm.es | ORCID https://orcid.org/0000-0001-7948-9889
Received 20 May 2025
Accepted 12 November 2025

HOW TO CITE
Cuéllar C, Hurtado-Marcos C, Valdivieso E, Vaccaro L, González-Fernández J, Jiménez AI, et al. Immune dysregulation, apoptosis impairment, and enhanced seroreactivity to Anisakis simplex in Crohn’s disease: interplay of IL-7/IL-7R signalling and CD132 deficiency. Mem Inst Oswaldo Cruz. 2025; 120: e250129.

HANDLING EDITOR
Marcelo Pelajo Machado | ORCID https://orcid.org/0000-0002-7295-7018

Our Location

Memórias do Instituto Oswaldo Cruz

Av. Brasil 4365, Castelo Mourisco 
sala 201, Manguinhos, 21040-900 
Rio de Janeiro, RJ, Brazil

Tel.: +55-21-2562-1222

This email address is being protected from spambots. You need JavaScript enabled to view it.

Support Program

logo iocb

logo governo federal03h 
faperj   cnpq capes